Website News and Research

RSS

NSCLC treatment market forecast to reach $7.9 billion by 2020

The Non-Small Cell Lung Cancer treatment market will be driven primarily by the introduction of numerous premium therapies, particularly in second-line and squamous cell treatment settings, which either replace or combine with generic chemotherapies.

2 Jun 2015

Veritas Genetics introduces genetic screen for hereditary breast and ovarian cancer risk

Boston-based Veritas Genetics is launching its mission to disrupt the genetic testing industry and bring personalized medicine and prevention to the forefront, allowing individuals to take more control of their health.

2 Jun 2015

Poster related to Cantex's lead compound CX-01 presented at ASCO 2015

Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications that block critical mechanisms by which cancer spreads and resists treatment, today announced Tibor Kovacsovics, M.D., Medical Director for the Inpatient Service of the Division of Hematology and Hematologic Malignancies and Director of Hematologic Malignancy Clinical Research at Huntsman Cancer Institute presented a poster related to Cantex's lead compound, CX-01, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO).

1 Jun 2015

North American Spine Society issues formal coverage recommendation for MIS SI joint fusion

SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System®, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that the North American Spine Society (NASS) has issued their formal coverage recommendation for MIS SI joint fusion titled "Percutaneous Sacroiliac Joint Fusion, Defining Appropriate Coverage Positions."

1 Jun 2015

Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

Mirati Therapeutics, Inc. today presented data that demonstrated preliminary evidence of clinical activity from its investigational targeted tyrosine kinase inhibitor candidate, MGCD265, as part of the developmental therapeutics category at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago from May 29-June 2, 2015.

1 Jun 2015

Smartphone digital ruler ensures correctly-fitting condom

From now on, men around the world can make sure they get the right size condoms by measuring their penis with their smartphone. On the mobile website MeasureYourPenis.today, men can measure the girth of their penis by placing it on a digital ruler. Seven different colour codes representing different girths are used to provide advice and an additional explanation about condom sizes.

1 Jun 2015

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, presented additional preclinical data at the American Association of Cancer Research (AACR) Advances in Brain Cancer Research Conference on the potential for its lead product candidate VAL-083 (dianhydrogalactitol) to treat patients with temozolomide-resistant glioblastoma multiforme (GBM).

1 Jun 2015

Researchers identify 763 proteins in human aqueous humor that nourish the cornea and the lens

Researchers conducting a comprehensive proteomics analysis of human aqueous humor samples identified 763 proteins - including 386 proteins detected for the first time - in this clear fluid that helps maintain pressure in the eye and nourishes the cornea and the lens.

30 May 2015

BioDelivery Sciences calls for new treatment options for opioid addiction

As the rate of opioid abuse soars to new levels, growing recognition of the problem is garnering unprecedented media attention—as well as motivating innovative new approaches to better treatment.

30 May 2015

Global market for asthma treatment expected to reach $21.7 billion by 2020

Despite generic erosion facing several of the leading asthma brands, such as Advair (fluticasone propionate/salmeterol xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), the global market for asthma treatment is set to witness moderate growth by the end of the decade.

29 May 2015

AAWC educates public on current, evidence-based practices in wound care

Educating the community continues to be a major focus of the Association for the Advancement of Wound Care (AAWC), which was incorporated in 1995.

29 May 2015

TxCell reports results from annual general meeting of shareholders

TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today announces results of its annual general meeting of shareholders held in Valbonne, France.

28 May 2015

New, authoritative website launched to educate people about mesothelioma

Mesothelioma.us is a new and authoritative website that is devoted to educating people about the rare form of cancer, mesothelioma. For people who have been diagnosed with mesothelioma and their friends and loved ones who wish to know more about the disease and its treatment options, the new website is one-stop mesothelioma information stop.

27 May 2015

HUYA Bioscience International named winner of bronze Stevie Award

HUYA Bioscience International has been named the winner of a bronze Stevie Award in the Health Products & Services and Pharmaceuticals category in the second annual Asia-Pacific Stevie Awards.

26 May 2015

CORD calls upon governments, others to join forces to make Canada's Rare Disease Strategy a reality

Today, on Parliament Hill, the Canadian Organization for Rare Disorders released Canada's Rare Disease Strategy and called upon the federal, provincial and territorial governments along researchers, healthcare providers, educators, employers, and the patient community to join forces to make the Strategy a reality.

26 May 2015

Banook Group consolidates three subsidiaries under one unique name and brand

Banook Group, an international provider of cardiac safety, central imaging and endpoint adjudication services, today announces that its three subsidiaries will now be combined into one unique name and brand.

21 May 2015

DF/BWCC introduces new website to provide information about precision cancer medicine

Precision cancer medicine - diagnosis and treatment based on the genetic abnormalities of a specific tumor - is playing an ever-larger role in cancer care. The field got a boost earlier this year when President Barack Obama proposed a $215 million federal Precision Medicine Initiative with cancer as one of its priorities.

21 May 2015

New research project aims to improve music listening experiences in people with hearing impairments

Beethoven composed some of his most famous works after he became profoundly deaf. More recently, musicians such as Ozzy Osbourne, Brian Wilson and Phil Collins have encountered problems with their hearing. Tinnitus affects many more, from Eric Clapton and Neil Young to will.i.am.

21 May 2015

AACC receives three 2015 Hermes Creative Awards

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that it has received three 2015 Hermes Creative Awards. These awards recognize the association for the exceptional writing and design of its news publications and website, which help laboratory medicine professionals worldwide stay informed about important issues in the field and find solutions to challenging patient health problems.

20 May 2015

Simple blood test can predict evidence of TBI on radiographic imaging, injury severity

New study results show that a simple blood test to measure brain-specific proteins released after a person suffers a traumatic brain injury (TBI) can reliably predict both evidence of TBI on radiographic imaging and injury severity.

19 May 2015

Website News and Research

NSCLC treatment market forecast to reach $7.9 billion by 2020

Veritas Genetics introduces genetic screen for hereditary breast and ovarian cancer risk

Poster related to Cantex's lead compound CX-01 presented at ASCO 2015

North American Spine Society issues formal coverage recommendation for MIS SI joint fusion

Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

Smartphone digital ruler ensures correctly-fitting condom

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

Researchers identify 763 proteins in human aqueous humor that nourish the cornea and the lens

BioDelivery Sciences calls for new treatment options for opioid addiction

Global market for asthma treatment expected to reach $21.7 billion by 2020

AAWC educates public on current, evidence-based practices in wound care

TxCell reports results from annual general meeting of shareholders

New, authoritative website launched to educate people about mesothelioma

HUYA Bioscience International named winner of bronze Stevie Award

CORD calls upon governments, others to join forces to make Canada's Rare Disease Strategy a reality

Banook Group consolidates three subsidiaries under one unique name and brand

DF/BWCC introduces new website to provide information about precision cancer medicine

New research project aims to improve music listening experiences in people with hearing impairments

AACC receives three 2015 Hermes Creative Awards

Simple blood test can predict evidence of TBI on radiographic imaging, injury severity

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News